Skip to content
Screener

Globalstar GSAT Fair value of the warrant issued to Thermo for the guarantee associated with the 2023 Funding Agreement

Fair value of the warrant issued to Thermo for the guarantee associated with the 2023 Funding Agreement at other companies

Iron Mountain logo
Iron MountainIRM
-$41.94M
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$5.27M
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$5.27M
Grow Generation logo
Grow GenerationGRWG
$8M
Grow Generation logo
Grow GenerationGRWG
8M
Five9 logo
Five9FIVN
$0

Other financials

Income statement

See full
Revenue$64.8M-3.5%
Operating income-$4.8M-178%
Net income-$26.5M-238%
EPS (diluted)-$0.23-277%

Balance sheet

See full
Cash & equivalents$409.8M+32.9%
Total debt$419.1M-23.6%
Total equity$292.6M-18.9%
Total assets$2.4B+28.1%

Cash flow

See full
Operating cash flow$124.5M-21.1%
CapEx$1.6M-5.1%
Free cash flow$123.0M-21.3%

Valuation

See full
Market cap$10.81B+202%
Enterprise value$10.81B+183%
P/S38.5×+24.8×

Profitability

See full
Gross margin91.4%
Operating margin4.8%+3.7pp
Net margin-19.4%+9.0pp
FCF margin201.6%-19.9pp

Returns & leverage

See full
Return on equity-16.7%+26.6pp
Debt / equity1.4×-0.1×
Current ratio1.5×-1.3×

Where this comes from

Reported directly by Globalstar in its filing.

Tagged under the XBRL concept gsat:WarrantsIssued.

The source filing: Globalstar’s 10-K, filed February 27, 2026. Open the filing →

Filed
Feb 27, 2026, 4:27 PM EST
Fiscal year
FY2025
Accession
0001366868-26-000012

FAQ

What is Globalstar's fair value of the warrant issued to thermo for the guarantee associated with the 2023 funding agreement?
Globalstar (GSAT) reported fair value of the warrant issued to thermo for the guarantee associated with the 2023 funding agreement of $0 in Q4 2025.
What does fair value of the warrant issued to thermo for the guarantee associated with the 2023 funding agreement mean?
This metric represents the fair value of equity warrants issued to a third party as consideration for a financial guarantee or credit support. It captures the non-cash cost of securing financing, reflecting the dilution risk to existing shareholders in exchange for capital access. Investors monitor this to assess the total cost of capital beyond stated interest rates.

Ask your AI about Globalstar's fair value of the warrant issued to thermo for the guarantee associated with the 2023 funding agreement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude